5AM Venture Management as of March 31, 2025
Portfolio Holdings for 5AM Venture Management
5AM Venture Management holds 31 positions in its portfolio as reported in the March 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Entrada Therapeutics (TRDA) | 15.1 | $40M | 4.4M | 9.04 | |
| Enliven Therapeutics (ELVN) | 9.8 | $26M | 1.3M | 19.68 | |
| Dianthus Therapeutics (DNTH) | 7.1 | $19M | 1.0M | 18.14 | |
| Skye Bioscience Com New (SKYE) | 6.0 | $16M | 9.9M | 1.59 | |
| Pharvaris N V (PHVS) | 4.7 | $13M | 798k | 15.70 | |
| Centessa Pharmaceuticals Sponsored Ads (CNTA) | 4.5 | $12M | 831k | 14.38 | |
| Camp4 Therapeutics Corp (CAMP) | 4.4 | $12M | 2.9M | 4.00 | |
| Biohaven (BHVN) | 4.4 | $12M | 479k | 24.04 | |
| Moonlake Immunotherapeutics Class A Ord (MLTX) | 4.2 | $11M | 282k | 39.07 | |
| Miragen Therapeutics (VRDN) | 3.8 | $9.9M | 737k | 13.48 | |
| Tectonic Therapeutic (TECX) | 3.4 | $9.1M | 512k | 17.71 | |
| Celldex Therapeutics Com New (CLDX) | 3.4 | $9.0M | 497k | 18.15 | |
| Tyra Biosciences (TYRA) | 3.3 | $8.7M | 939k | 9.30 | |
| Erasca (ERAS) | 2.8 | $7.4M | 5.4M | 1.37 | |
| Artiva Biotherapeutics (ARTV) | 2.7 | $7.1M | 2.4M | 3.00 | |
| Anaptysbio Inc Common (ANAB) | 2.5 | $6.7M | 358k | 18.59 | |
| Praxis Precision Medicines I Com New (PRAX) | 2.4 | $6.4M | 170k | 37.87 | |
| Gh Research Ordinary Shares (GHRS) | 2.4 | $6.3M | 573k | 11.03 | |
| Eyepoint Pharmaceuticals Com New (EYPT) | 2.2 | $5.7M | 1.1M | 5.42 | |
| Viking Therapeutics (VKTX) | 1.7 | $4.6M | 190k | 24.15 | |
| Vor Biopharma | 1.7 | $4.6M | 6.4M | 0.72 | |
| Surrozen Com New (SRZN) | 1.4 | $3.6M | 310k | 11.66 | |
| Protara Therapeutics Com Stk (TARA) | 1.3 | $3.4M | 800k | 4.26 | |
| Scpharmaceuticals (SCPH) | 1.2 | $3.2M | 1.2M | 2.63 | |
| Rallybio Corp (RLYB) | 0.9 | $2.4M | 3.6M | 0.65 | |
| Adverum Biotechnologies Com New (ADVM) | 0.9 | $2.4M | 542k | 4.37 | |
| Silence Therapeutics Ads (SLN) | 0.5 | $1.3M | 476k | 2.82 | |
| Alector (ALEC) | 0.5 | $1.2M | 996k | 1.23 | |
| Cidara Therapeutics Com New (CDTX) | 0.5 | $1.2M | 57k | 21.54 | |
| Zentalis Pharmaceuticals (ZNTL) | 0.3 | $779k | 490k | 1.59 | |
| Mersana Therapeutics | 0.2 | $449k | 1.3M | 0.34 |
